Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Leadership
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Leadership
        • San Francisco Contacts
      • Seattle
        • Seattle Leadership
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Foreign Divisions
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Asia Pacific
        • Asia Pacific Leadership
      • Middle East
      • North and Central America
      • Southern Cone
    • Operational Divisions
      • Aviation Division
      • Diversion Control Division
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
      • Special Agent Job Announcements
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
      • Employment Requirements
      • Equal Opportunity Employer
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
  • Resources
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Foreign Divisions
    • Operational Divisions
    • Wall of Honor
    • Contact Us
  • What We Do
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
  • Resources
    • Recovery Resources
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Drug Enforcement Administration

Jarod A. Forget Special Agent in Charge
Washington, DC
@DEAWashingtonDC
June 08, 2016
Contact: Public Information Office
Phone Number: (571) 362-1934
For Immediate Release

Nurse-Practitioner Indicted On Federal Charges, Accused Of Illegally Distributing Oxycodone

Defendant ran pain management practice in Southeast Washington

(WASHINGTON - Ivan Lamont Robinson, a licensed nurse practitioner who was based in Southeast Washington, has been indicted on federal charges that he distributed oxycodone outside the legitimate scope of professional practice and without a legitimate medical purpose. 

The indictment was announced by Karl C. Colder, Special Agent in Charge of the Washington Division Office of the Drug Enforcement (DEA); U.S. Attorney Channing D. Phillips; Nicholas DiGiulio, Special Agent in Charge of the U.S. Department of Health and Human Services, Office of Inspector (HHS-OIG), for the region that includes Washington, D.C.; Robert E. Craig, Jr., Special Agent in Charge of the Mid-Atlantic Field Office of the Defense Criminal Investigative (DCIS), and Cathy L. Lanier, Chief of the Metropolitan Police (MPD).

Robinson, 44, of Washington, D.C., was indicted on June 7, 2016, by a grand jury in the U.S. District Court for the District of Columbia, on a total of 55 felony counts. The indictment became public today, and Robinson is to appear in court at a later date. The case is assigned to the Honorable Colleen Kollar-Kotelly. Each of the 55 counts carries a statutory maximum of 20 years in prison and a maximum fine of $1 million. Under federal sentencing guidelines, the charges carry a potential range of 97 to 121 months in prison.

According to the government’s evidence, Robinson conducted a pain management practice from 2011 until 2013 in the 2000 block of Martin Luther King Jr. Avenue SE. His practice received numerous complaints from civilians in the area and from other health care professionals, including pharmacists, who suspected that he was operating a “pill mill” rather than a medical pain management practice. 

Law enforcement executed numerous search warrants involving his practice on June 19, 2013.  After a meeting with DEA officials, he voluntarily relinquished his DEA license, which had authorized him to write prescriptions for controlled substance medication.  Under D.C. Board of Health rules, he had been permitted to write prescriptions and treat certain patients without supervision by a licensed physician. The indictment alleges that he wrote 55 prescriptions for various patients.  Each patient received the same prescription, that is, 60 tablets of 30 mg oxycodone.

“Pill mill” prosecutions are common in the United States, but this appears to be the first of its kind to be prosecuted by the U.S. Attorney’s Office for the District of Columbia. “Pill mill” is a shorthand terminology for a medical practice which begins selling prescriptions to customers, usually for cash.  Pill mill practices are characterized by practitioners who cease treating patients.  For example, when a health care professional ceases conducting medical histories of patients, refrains from conducting physical examinations, neglects to keep adequate medical records listing diagnosis and treatment plans, and simply sells patients prescriptions for opioids, like oxycodone, in exchange for cash, then such conduct is not in the usual course of professional practice.  In those instances, health care professionals can face prosecution for distribution of controlled substances.

“Most health care professionals adhere to strict standards when caring for their patients,” said Special Agent in Charge Colder. “However, in this instance, Mr. Robinson is accused of using his position to prescribe oxycodone for the sole purpose of making money, ultimately putting lives in danger. This indictment, numerous search warrants and subsequent arrest demonstrates that DEA is dedicated to dismantling “pill mill” operations. When prescriptions are obtained through rogue pain management clinics and then sold on the streets, it creates and feeds a new generation of users and addicts. These addicts will continue to abuse the illegal prescriptions, or switch to a cheaper and more potent drug; heroin. DEA would like to thank its law enforcement partners for their diligent efforts to keep the citizens of Washington, D.C. safe.”

“Doctors and health care professionals have a responsibility to the public to prescribe opioid medications carefully, and when there is a legitimate medical purpose to do so, and not merely to feed someone’s addiction,” said U.S. Attorney Phillips. “Together with our law enforcement partners, we are committed to combatting the problem of opioid abuse.”
 
“This indictment is part of an ongoing effort by the Defense Criminal Investigative (DCIS) to aggressively investigate allegations of health care fraud that affect the Department of Defense and put its personnel at risk,” said Special Agent in Charge Craig. “DCIS will continue working with our law enforcement partners to make health care fraud an investigative priority.”
           
According to the Center for Disease Control, in 2011, three-quarters of prescription overdose deaths involved a prescription for an opioid pain reliever, such as oxycodone.  While these medicines have a legitimate medical use for alleviating pain, they are in such great demand that opioids and heroin are now the number one drug threat to our region and to the nation. As President Obama pointed out in May 2016, "Drug overdoses now take more lives every year than traffic accidents. Deaths from opioid overdoses have tripled since 2000. A lot of the time, they're from legal drugs prescribed by a doctor.”

An indictment is merely a formal charge that a defendant has committed a violation of criminal laws and every defendant is presumed innocent until, and unless, proven guilty.

In announcing the indictment, Special Agent in Charge Colder, U.S. Attorney Phillips, Special Agent in Charge DiGiulio, Special Agent in Charge Craig, and Chief Lanier commended the work of Assistant U.S. Attorneys John P. Dominguez and John Han, who are prosecuting the case. They also expressed appreciation for the assistance provided by Paralegal Specialist Jeannette Litz of the U.S. Attorney’s Office. Finally, they acknowledged the work of those who are investigating the case, including Metropolitan Police Department Officer Karen Taylor Arikpo and DEA Drug Diversion Investigator Shirley Powell, both from the DEA’s Tactical Drug Diversion Squad; Special Agent Tracy McFadden of the Office of Inspector General for the U.S. Department of Health and Human Services; and Special Agent Nacieve Owens of the Department of Defense, Defense Criminal Investigative Service. 

  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Drug Prevention
    • Law Enforcement
    • Diversion Control Division
    • News
  • Careers
    • Overview
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
  • Resources
    • Drug Information
    • Employee Assistance Program
    • Equal Opportunity Employer
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
  • Policies
    • Accessibility, Plug-ins & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
Home

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster